SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-19-007804
Filing Date
2019-02-14
Accepted
2019-02-14 11:51:41
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv513686_sc13g.htm SC 13G 51643
  Complete submission text file 0001144204-19-007804.txt   53270
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 19603145
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820
Business Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G